Press Releases 2004

The Prostate Cancer Foundation Appoints Craig A. Dionne, Ph.D. as Executive Vice President of Research and Therapeutics

Los Angeles - November 11, 2004 - The Prostate Cancer Foundation (PCF) today announced the appointment of Craig A. Dionne, Ph.D. as executive vice president of research and therapeutics. Dr. Dionne recently served as vice president, biological research at Cephalon, Inc., where he directed drug discovery programs in both oncology and neurobiology.  During his tenure at Cephalon, Dr. Dionne led many collaborative initiatives with academic research scientists and biopharmaceutical companies, and brought four novel drugs into clinical development.


Prostate Cancer Foundation Launches "Monument Park" Virtual Tribute Community

Kintera Sphere™ enterprise-level software platform provides innovative, online tribute/memorial area to honor men who have been diagnosed with prostate cancer
San Diego - Oct. 28 - Politicians and sports heroes, husbands and sons - they are all among the hundreds of thousands of men in the United States who have been diagnosed with prostate cancer. 
To honor those who have fought the disease, as well as men battling for their lives right now, the Prostate Cancer Foundation (PCF) announced today the launch of "Monument Park"  (www.prostatecancerfoundation.org/monumentpark), a virtual, online area for tributes and memorials for men who have been diagnosed with prostate cancer.  Using Internet tools developed by technology solutions provider Kintera® Inc. (NASDAQ: KNTA), web visitors can create their own Monument Park mini-site featuring a library of photos and memories for a loved one, or post a message on an individual's virtual monument site. 



The Prostate Cancer Foundation Announces 2004 Coffey Award Recipients at 11th Annual Scientific Retreat

SANTA MONICA, Oct. 25 - The Prostate Cancer Foundation today announced the recipients of the 2004 Donald S. Coffey-Prostate Cancer Foundation Physician-Scientist Awards during its 11th annual Scientific Retreat in Lake Tahoe, NV.  The Donald Coffey-Prostate Cancer Foundation Physician-Scientist Awards are designed to honor Dr. Coffey's decades-long commitment to prostate cancer research and his recognition of the important role physician-scientists play in research.  The four awardees were chosen for their compassionate and expert care of prostate cancer patients and excellent laboratory research that moved the field forward in a significant way.  The PCF recognizes the role that Dr. Coffey and the four awardees have played in improving the lives of all men affected by prostate cancer.


Prostate Cancer Foundation-Funded Scientist, Dr. Aaron Ciechanover, Awarded Nobel Prize in Chemistry

Santa Monica, October 6, 2004 -- Today's announcement by the Royal Swedish Academy of Sciences that Aaron Ciechanover, M.D., D.Sc., has won the 2004 Nobel Prize in Chemistry is a profoundly gratifying affirmation not only of his work, but also of the initiatives of the Prostate Cancer Foundation, which has provided Dr. Ciechanover with multiple research awards.


Blue For Men: The Prostate Cancer Foundation Announces New Partnerships To Kick Off National Prostate Cancer Awareness Month

LOS ANGELES, Sept. 9, 2004 -- Men hope to finally become as educated as women -- in terms of cancer awareness, that is.  The Prostate Cancer Foundation (PCF) announces exciting new partnerships with Esquire Magazine and several major designer clothing corporations including HUGO BOSS and Salvatore Ferragamo for the creation of the "Blue for Men" campaign, beginning September 2004, Prostate Cancer Awareness Month. 


Dollars Raised Through Voluntary Check-Off Will Be Matched by The Prostate Cancer Foundation

NEW YORK and SANTA MONICA, Aug. 3, 2004 -- Governor George E. Pataki and Senate Majority Leader Joseph L. Bruno today announced that the Governor has signed into law legislation that will create a new voluntary check-off box on State income tax forms, which will allow New York citizens and businesses to donate to prostate cancer research and prevention efforts.


Prostate Cancer Advocacy Groups Push for Clinical Trial Design Improvements to Facilitate the Development of New Treatment Options

Santa Monica, June 18, 2004 -- For the first time ever, the four major prostate cancer advocacy groups --Prostate Cancer Education Council (PCEC), National Prostate Cancer Coalition, Prostate Cancer Foundation and Us TOO International Prostate Cancer Education and Support Network -- are combining forces with the common goal of working with the U.S. Food and Drug Administration (FDA) to streamline the approval process for critical prostate cancer treatments by changing the traditional measures of a research study's success or failure, known as clinical trial endpoints, without compromising safety.

New Prostate Cancer Treatments in Development Top 200, Many Supported by the Prostate Cancer Foundation

LOS ANGELES, June 4, 2004 -- The Prostate Cancer Foundation (PCF) today announced that more than 200 new therapies are being developed for prostate cancer, many by researchers supported by the PCF.  Substantially more prostate cancer therapies are in later stages of clinical development (Phases II and III) than ever before.  There are now 10 new prostate cancer therapies in Phase III clinical trials compared to only four in 1997.  (Phase III clinical trials are large studies that are typically required prior to a drug receiving FDA approval.)  Even more dramatically, 90 new therapies are currently in Phase II clinical trials, compared with only 31 in 1997.

Celebs Support Prostate Cancer Foundation with Father's Day Charity Auction

SAN JOSE, Calif., May 24, 2004 -- From May 27 through June 21, you can log onto eBay and bid on a special Father's Day present for your dad, such as two hours with Magic Johnson, a day with Arnold Palmer, lunch with Don King or a meal with Miss Universe -- with all the proceeds benefiting the Prostate Cancer Foundation (PCF).

Prostate Cancer Foundation Teams Up with Arnold Palmer, AriZona Beverage and Lamkin to Fight Prostate Cancer

LOS ANGELES, March 9, 2004 -- The Prostate Cancer Foundation today announced major corporate alliances with Lamkin Corporation and AriZona Beverage Company to support crucial research to find new treatments and cures for prostate cancer.  Lamkin has made a five-year pledge to raise at least one million dollars for the Prostate Cancer Foundation's research initiatives, agreeing to donate a percentage of sales of its regrip products.  AriZona Beverage Company, in association with participating Safeway and Vons stores, will also donate to the Prostate Cancer Foundation a portion of the proceeds from the sale of cans of Lemon, Raspberry, Green Tea and Arnold Palmer's Half'n Half Lite.  Safeway's 1,700 stores include Vons, Pavilions, Carrs, Dominick's, Randalls, Tom Thumb and Genuardi's.

LOS ANGELES, Jan. 12, 2004 -- The Prostate Cancer Foundation today announced the recipients of the Foundation's 2003 Competitive Research Awards. This venture-style research funding mechanism provides support to high-impact research projects with the highest likelihood of providing improved near-term treatments for men with prostate cancer.